Goldman Sachs analyst Brooke Roach lowered the firm's price target on Torrid to 75c from $1.50 and keeps a Sell rating on the shares. This was a "disappointing" update from Torrid and the firm is "incrementally" guarded on the business, the analyst tells investors. Profit is under significant pressure and sales trends remain weak, the firm adds.
